TickerTalks
Browse all tickers →
TickerTalks›$CNXU
CNCNXU

Conexeu Sciences Inc.

$CNXU·$262M·Biotechnology·Healthcare
$13.28+2.0%1Y+1.6%
Mentions · last 7 days
0
Price updated 9h ago
CNCNXU
Conexeu Sciences Inc.$CNXU
$13.28+2.00%0 posts
Loading…

What it does

Plain-English summary of the business — what they sell and how they make money.

Develops regenerative biomaterials for wound management, dental, and aesthetic medicine applications.

Industry overviewAI analysisGenerated by AI from underlying data

Where Biotechnology sits in its cycle right now — and what that implies for $CNXU.

Biotechnology · Healthcare

GLP-1 obesity pipeline competition is the dominant structural driver — the 'next phase' of obesity drugs (oral formulations, differentiated mechanisms) is reshaping clinical bets for NVO competitors. Gene editing (CRSP, BEAM, NTLA, PRME) is transitioning from clinical to commercial-maturation phase with Casgevy scaling; oncology binary events (IBRX, ALLO, KURA) define the near-term calendar.

See how Biotechnology shapes $CNXU

  • Where the industry is in its cycle and the catalysts moving it now
  • What this means specifically for $CNXU's next move
  • Peer-basket or ETF benchmark you can use to gut-check the read
Free, forever. No credit card.

Top industry ETF

$IBBiShares Biotechnology ETF
+2.4%YTD
+38.1%1Y

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.—Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.—Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.—Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.—Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 15.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.005-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.FilingActive offeringA shelf registration (S-3 / S-3ASR / S-1) or prospectus supplement (424B*) was filed in the last 90 days — the company is registered to (or actively) issuing new shares. Dilution risk.

Know if $CNXU is setting up — or just chopping

  • Volume multiple vs 30-day baseline — catch unusual interest before the move
  • Position vs 50d & 200d MAs and 52-week range — trend direction at a glance
  • Float bucket, beta, and active-offering flags — what kind of stock you're trading
Free, forever. No credit card.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

No open-market buys or sells in the last 180 days.

+ 2 other (2 exempts) in window

See when $CNXU insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KUnregistered equity saleJun 98-K — Item 3.02: Unregistered equity sale
AI summary

Connexa Sports Technologies Inc. (CNXU) reported unregistered sales of equity securities (Item 3.02) in an 8-K filed June 9, 2026. Body unavailable — excerpt cuts off before the specific equity sale terms, share counts, or pricing are disclosed.

3New insider — initial holdingsMay 273
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 27, 2026 reporting initial beneficial ownership for a newly appointed director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

8-KUnregistered equity saleMay 158-K — Item 3.02: Unregistered equity sale · Item 5.03: Charter amendment
AI summary

Connexa Sports Technologies Inc. (CNXU) reported unregistered sales of equity securities (Item 3.02) and charter/bylaw amendments (Item 5.03) in an 8-K filed May 15, 2026. Body unavailable — excerpt cuts off before the specific equity terms or charter amendment details are disclosed.

3New insider — initial holdingsMay 113
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 11, 2026 reporting initial beneficial ownership for a newly designated director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

3New insider — initial holdingsMay 113
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 11, 2026 reporting initial beneficial ownership for a newly designated director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

3New insider — initial holdingsMay 113
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 11, 2026 reporting initial beneficial ownership for a newly designated director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

3New insider — initial holdingsMay 113
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 11, 2026 reporting initial beneficial ownership for a newly designated director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

3New insider — initial holdingsMay 113
AI summary

Connexa Sports Technologies Inc. (CNXU) filed a Form 3 on May 11, 2026 reporting initial beneficial ownership for a newly designated director, officer, or 10%+ holder. Body unavailable — excerpt contains only SEC cover-page header.

+ 26 other (7 Ds · 6 3s · 6 S-1/As · 1 10-Q) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listingglobenewswire.com·4d agoConexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Programglobenewswire.com·11d agoConexeu Sciences to Ring Nasdaq Bell on June 10, 2026globenewswire.com·16d agoUPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicineglobenewswire.com·23d agoConexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicineglobenewswire.com·23d ago

More in Biotechnology

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$ALLO$NVO$AURA$HUMA$ALT$IBRX$QURE$RXRX
Voices on X · top 1 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport